Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

PHASE3CompletedINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Hepatitis C
Interventions
DRUG

BI201335

QD BI 201335

DRUG

PegIFN/RBV

DRUG

BI201335

QD (once daily) BI 201335

DRUG

Placebo

Trial Locations (106)

Unknown

1220.47.0004 Boehringer Ingelheim Investigational Site, Birmingham

1220.47.0045 Boehringer Ingelheim Investigational Site, Birmingham

1220.47.0050 Boehringer Ingelheim Investigational Site, Dothan

1220.47.0061 Boehringer Ingelheim Investigational Site, Phoenix

1220.47.0091 Boehringer Ingelheim Investigational Site, North Little Rock

1220.47.0008 Boehringer Ingelheim Investigational Site, Bakersfield

1220.47.0019 Boehringer Ingelheim Investigational Site, Chula Vista

1220.47.0010 Boehringer Ingelheim Investigational Site, Coronado

1220.47.0033 Boehringer Ingelheim Investigational Site, La Jolla

1220.47.0035 Boehringer Ingelheim Investigational Site, La Mesa

1220.47.0011 Boehringer Ingelheim Investigational Site, Los Angeles

1220.47.0014 Boehringer Ingelheim Investigational Site, Los Angeles

1220.47.0100 Boehringer Ingelheim Investigational Site, Los Angeles

1220.47.0018 Boehringer Ingelheim Investigational Site, Oceanside

1220.47.0059 Boehringer Ingelheim Investigational Site, Poway

1220.47.0024 Boehringer Ingelheim Investigational Site, San Diego

1220.47.0037 Boehringer Ingelheim Investigational Site, San Diego

1220.47.0031 Boehringer Ingelheim Investigational Site, San Francisco

1220.47.0082 Boehringer Ingelheim Investigational Site, Englewood

1220.47.0049 Boehringer Ingelheim Investigational Site, New Haven

1220.47.0057 Boehringer Ingelheim Investigational Site, Bradenton

1220.47.0078 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1220.47.0086 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1220.47.0054 Boehringer Ingelheim Investigational Site, Hialeah

1220.47.0088 Boehringer Ingelheim Investigational Site, Miami

1220.47.0044 Boehringer Ingelheim Investigational Site, Orlando

1220.47.0099 Boehringer Ingelheim Investigational Site, Orlando

1220.47.0095 Boehringer Ingelheim Investigational Site, Palm Harbor

1220.47.0074 Boehringer Ingelheim Investigational Site, Tampa

1220.47.0022 Boehringer Ingelheim Investigational Site, Atlanta

1220.47.0039 Boehringer Ingelheim Investigational Site, Columbus

1220.47.0052 Boehringer Ingelheim Investigational Site, Decatur

1220.47.0013 Boehringer Ingelheim Investigational Site, Chicago

1220.47.0055 Boehringer Ingelheim Investigational Site, Chicago

1220.47.0062 Boehringer Ingelheim Investigational Site, Vaiparaiso

1220.47.0085 Boehringer Ingelheim Investigational Site, Baton Rouge

1220.47.0087 Boehringer Ingelheim Investigational Site, Baton Rouge

1220.47.0101 Boehringer Ingelheim Investigational Site, New Orleans

1220.47.0064 Boehringer Ingelheim Investigational Site, Baltimore

1220.47.0069 Boehringer Ingelheim Investigational Site, Baltimore

1220.47.0067 Boehringer Ingelheim Investigational Site, Chevy Chase

1220.47.0079 Boehringer Ingelheim Investigational Site, Lutherville

1220.47.0027 Boehringer Ingelheim Investigational Site, Framingham

1220.47.0065 Boehringer Ingelheim Investigational Site, Springfield

1220.47.0023 Boehringer Ingelheim Investigational Site, Tulepo

1220.47.0046 Boehringer Ingelheim Investigational Site, Las Vegas

1220.47.0066 Boehringer Ingelheim Investigational Site, Neptune City

1220.47.0083 Boehringer Ingelheim Investigational Site, Brooklyn

1220.47.0003 Boehringer Ingelheim Investigational Site, New York

1220.47.0006 Boehringer Ingelheim Investigational Site, New York

1220.47.0038 Boehringer Ingelheim Investigational Site, New York

1220.47.0090 Boehringer Ingelheim Investigational Site, New York

1220.47.0097 Boehringer Ingelheim Investigational Site, The Bronx

1220.47.0053 Boehringer Ingelheim Investigational Site, Charlotte

1220.47.0021 Boehringer Ingelheim Investigational Site, Winston-Salem

1220.47.0098 Boehringer Ingelheim Investigational Site, Tulsa

1220.47.0028 Boehringer Ingelheim Investigational Site, Portland

1220.47.0058 Boehringer Ingelheim Investigational Site, Portland

1220.47.0030 Boehringer Ingelheim Investigational Site, Germantown

1220.47.0072 Boehringer Ingelheim Investigational Site, Jackson

1220.47.0032 Boehringer Ingelheim Investigational Site, Nashville

1220.47.0041 Boehringer Ingelheim Investigational Site, Nashville

1220.47.0063 Boehringer Ingelheim Investigational Site, Arlington

1220.47.0029 Boehringer Ingelheim Investigational Site, Austin

1220.47.0017 Boehringer Ingelheim Investigational Site, Dallas

1220.47.0056 Boehringer Ingelheim Investigational Site, Dallas

1220.47.0071 Boehringer Ingelheim Investigational Site, Dallas

1220.47.0060 Boehringer Ingelheim Investigational Site, Fort Worth

1220.47.0081 Boehringer Ingelheim Investigational Site, Forth Worth

1220.47.0009 Boehringer Ingelheim Investigational Site, Houston

1220.47.0068 Boehringer Ingelheim Investigational Site, Houston

1220.47.0016 Boehringer Ingelheim Investigational Site, San Antonio

1220.47.0015 Boehringer Ingelheim Investigational Site, Burlington

1220.47.0042 Boehringer Ingelheim Investigational Site, Annandale

1220.47.0043 Boehringer Ingelheim Investigational Site, Falls Church

1220.47.0026 Boehringer Ingelheim Investigational Site, Richmond

1220.47.0092 Boehringer Ingelheim Investigational Site, Seattle

1220.47.0073 Boehringer Ingelheim Investigational Site, Milwaukee

1220.47.1011 Boehringer Ingelheim Investigational Site, Calgary

1220.47.1012 Boehringer Ingelheim Investigational Site, Edmonton

1220.47.1001 Boehringer Ingelheim Investigational Site, Vancouver

1220.47.1003 Boehringer Ingelheim Investigational Site, Vancouver

1220.47.1016 Boehringer Ingelheim Investigational Site, Vancouver

1220.47.1007 Boehringer Ingelheim Investigational Site, Victoria

1220.47.1009 Boehringer Ingelheim Investigational Site, Winnipeg

1220.47.1013 Boehringer Ingelheim Investigational Site, Hamilton

1220.47.1002 Boehringer Ingelheim Investigational Site, London

1220.47.1004 Boehringer Ingelheim Investigational Site, Ottawa

1220.47.1005 Boehringer Ingelheim Investigational Site, Toronto

1220.47.1006 Boehringer Ingelheim Investigational Site, Toronto

1220.47.1015 Boehringer Ingelheim Investigational Site, Toronto

1220.47.1010 Boehringer Ingelheim Investigational Site, Montreal

1220.47.1014 Boehringer Ingelheim Investigational Site, Montreal

1220.47.0034 Boehringer Ingelheim Investigational Site, San Juan

1220.47.8204 Boehringer Ingelheim Investigational Site, Pusan

1220.47.8205 Boehringer Ingelheim Investigational Site, Pusan

1220.47.8203 Boehringer Ingelheim Investigational Site, Seongnam

1220.47.8202 Boehringer Ingelheim Investigational Site, Seoul

1220.47.8206 Boehringer Ingelheim Investigational Site, Seoul

1220.47.8207 Boehringer Ingelheim Investigational Site, Seoul

1220.47.8201 Boehringer Ingelheim Investigational Site, Yangsan

1220.47.8803 Boehringer Ingelheim Investigational Site, Kaohsiung City

1220.47.8804 Boehringer Ingelheim Investigational Site, Kaohsiung City

1220.47.8802 Boehringer Ingelheim Investigational Site, Taichung

1220.47.8801 Boehringer Ingelheim Investigational Site, Taipei

1220.47.8805 Boehringer Ingelheim Investigational Site, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY